Your browser doesn't support javascript.
loading
Cost-Effectiveness of Abemaciclib in Early Breast Cancer Patients: One Size Fits All or Tailoring to Patients' Needs?
Jongbloed, Elisabeth M; Blommestein, Hedwig M; van Schoubroeck, Hannah M; Martens, John W M; Wilting, Saskia M; Uyl-de Groot, Carin A; Jager, Agnes.
Afiliación
  • Jongbloed EM; Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Blommestein HM; Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands.
  • van Schoubroeck HM; Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands.
  • Martens JWM; Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Wilting SM; Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Uyl-de Groot CA; Erasmus School of Health Policy and Management, Erasmus University, Rotterdam, the Netherlands.
  • Jager A; Department of Medical Oncology; Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Article en En | MEDLINE | ID: mdl-36814469

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Breast Cancer (Dove Med Press) Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Nueva Zelanda

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Breast Cancer (Dove Med Press) Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Nueva Zelanda